drugset / Trial / NCT05354076
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
NaSingle-groupOpen-labelTreatment
Summary
To study the correlation between the content of natural IgM in patients' blood samples and liposomal doxorubicin for clinical use, and to explore the possibility of using natural IgM content to guide clinical accurate medication.
Timeline
- Start
- 2000-03-01
- Primary completion
- 2022-06-01
- Completion
- 2022-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 35 mg/m2 | — |